98%
921
2 minutes
20
Background: Lung retransplantation is offered to select patients with chronic allograft dysfunction. Given the increased risk of morbidity and mortality conferred by retransplantation, post-transplant function should be considered in the decision of who and when to list. The aim of this study is to identify predictors of post-operative disability in patients undergoing lung retransplantation.
Methods: Data were collected from the UNOS national dataset and included all patients who underwent lung retransplant from May 2005-March 2023. Pre- and post-operative function was reported by the Karnofsky Performance Status (KPS) and patients were stratified based on their needs. Cumulative link mixed effects models identified associations between pre-transplant variables and post-transplant function.
Results: A total of 1275 lung retransplant patients were included. After adjusting for between-group differences, pre-operative functional status was predictive of post-transplant function; patients requiring Total Assistance ( n = 740) were 74% more likely than No/Some Assistance patients (n = 535) to require more assistance in follow-up (OR 1.74, 95% CI 1.13-2.68, p = .012). Estimated one year survival of Total Assistance patients is lower than No/Some Assistance Recipients (72% vs. 82%, CI 69%-75%; 79%-86%) but similar to overall re-transplant survival (76%, CI 74%-79%).
Conclusion: Both survival and regain of function in patients requiring Total Assistance prior to retransplant may be higher than previously reported. Pre-operative functional status is predictive of post-operative function and should weigh in the selection, timing and post-operative care of patients considered for lung retransplantation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11381089 | PMC |
http://dx.doi.org/10.1111/ctr.15310 | DOI Listing |
Clin Transplant
August 2025
Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Background: Highly sensitized patients with advanced lung disease, who are more often Black and Hispanic women, are at increased risk for waitlist death. In 2012, we implemented a protocol to cross any pre-transplant donor-specific antibody (DSA), so long as a prospective complement-dependent cytotoxicity (CDC) crossmatch was negative. We report long-term outcomes, including overall survival and chronic lung allograft dysfunction (CLAD)-free survival.
View Article and Find Full Text PDFJ Heart Lung Transplant
July 2025
Section of Pulmonary Critical Care, The University of Chicago Medicine, Chicago, IL; Department of Public Health Sciences, University of Chicago, Chicago, IL; MacLean Center for Clinical Medical Ethics, University of Chicago, Chicago, IL. Electronic address:
Background: In the US, donor hearts for transplant are currently allocated to the candidates with the highest risk of death on the waiting list, based on a categorical status-based system. The upcoming continuous distribution system provides an opportunity to implement a post-transplant risk score that may help avoid futile transplants.
Methods: In this observational study of the Scientific Registry of Transplant Recipients (SRTR), a novel US transplant risk score (US-TRS) was developed and validated using a mixed-effects Cox proportional hazards model.
JHLT Open
August 2025
Division of Pediatric Pulmonology, Boston Children's Hospital and Harvard Medical School, Boston, MA.
The year 2025 marks an important landmark: almost 40 years since the first pediatric lung transplant (LTX), over 3-5 years since the availability of elexacaftor/tezacaftor/ivacaftor in several countries, and 5-10 years since striking shifts were reported in the diagnoses that accounted for pediatric LTX. We review historic indications for pediatric LTX, highlighting shifts in these over time, and analyze data from the ISHLT International Thoracic Organ Transplant Registry, United Network of Organ Sharing, Canadian Cystic Fibrosis (CF) Registry, and other databases up to the present day. Currently, pediatric CF-related LTX cases are at record lows in many countries.
View Article and Find Full Text PDFVideoGIE
June 2025
Division of Gastroenterology, Hepatology, and Nutrition, University of Florida College of Medicine, Gainesville, Florida, USA.
Background And Aims: A patient with a prior lung transplant and surgical fundoplication had severe recurrent gastroesophageal reflux disease (GERD) and chronic retrograde microaspiration, which both threatened his graft function and elevated his risk for retransplant. He was deemed a poor candidate for surgical fundoplication. We therefore aimed to perform a transoral incisionless fundoplication (TIF).
View Article and Find Full Text PDFJ Heart Lung Transplant
September 2025
Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California. Electronic address:
Background: Obesity is an ongoing pandemic, and the rising trend of body mass index (BMI) in heart transplant (HTx) recipients is well known. However, the long term post-HTx outcomes of obese patients are not clearly documented.
Aims: We aimed to investigate long term post-transplant outcomes in obese patients.